Over the past week, the village of al-Aour in the governorate of Minya—home to thirteen of the twenty Coptic Egyptian victims killed by the Islamic State (ISIS) in Libya—has been transformed. The once obscure village has become a site for official delegations and mourners to visit, and offer condolences and support to the bereaved families of the victims. This influx of visitors is new for al-Aour.
The fate of 20 Egyptian Copts, who were kidnapped by masked men in two separate incidents in the Libyan city of Sirte, remains unclear. In the first kidnapping, which took place on December 31, 2014, militants forcefully stopped a microbus transporting Egyptians and kidnapped seven Christians at gunpoint.
Egyptian courts have allowed alleged perpetrators of killings and torture from security agencies to walk free, sometimes without ever appearing in court, while relatives of those killed by police brutality suffer in silence.
On June 5, 2014, an amendment to the Egyptian Penal Code saw the introduction of harassment as a definitive crime. While the amendment does not fully satisfy the aspirations of many stakeholders, who fought for years to enact it (for example, the definition confines harassment to the act of stalking and following the victim, which excludes many acts of verbal harassment), it remains a crucial victory and an achievement worth celebrating.
In a previous article I pointed out four main Challenges for the housing minister in Providing adequate housing to the millions of families seeking their right to an affordable and safe home. Challenges One of these was making Government housing projects workTel.
Local newspapers recently reported that the first batch of sofosbuvir, the new drug for treating the hepatitis C virus (HCV), is expected to arrive in August, and the National Committee for the Control of Viral Hepatitis will start identifying the cases that will receive priority treatment.
Sofosbuvir, marketed under the name Sovaldi, is produced by the US-based multinational pharmaceutical company, Gilead Sciences Inc. It is an oral antiviral drug with high cure rates compared to the other antivirals, and is considered a breakthrough in the treatment of HCV.
In late April, a small group of us from Egyptian NGOs and independent movements attended the Middle East and North Africa (MENA) Regional Forum on monitoring places of detention and the prevention of torture in Beirut. The forum brings together people from across the region representing independent NGOs and movements, as well as the national offices of ombudspersons, to exchange experiences and best-practice on monitoring prisons and other detention facilities, with the aim of improving conditions and preventing torture and other ill-treatment.
On behalf of Egyptian participants in the Middle East and North Africa (MENA) Regional Forum on monitoring places of detention and the prevention of torture in Beirut between 23-27 April 2014 [ Hani Mostafa, al-Nadem; Taher Mukhtar, Tahrir Doctors; Reda Marii, EIPR, and Diana Eltahawy, EIPR]
When the Egyptian army's medical team announced it had invented two devices to detect and cure the viral infections HCV and HIV, it came under a fire of criticism from the scientific community.
The official announcement and subsequent statements by military spokespeople were fiercely ridiculed across social media platforms, but at the same time, others gave a standing ovation.
Amid the conflict currently underway in Egypt—between state authorities led by the military-backed government and the Muslim Brotherhood and their Islamist allies—another momentous battle is being waged over the country’s mosques and pulpits. Sermons, religious lessons, and charitable and development activities centered in mosques are an important sphere of influence for Islamist movements of various stripes.